Veradigm Inc.: Nasdaq/NYSE listing notice — Veradigm receives Nasdaq delisting notice; trading suspended Feb. 29, 2024

Veradigm Inc.

Noncompliant with Nasdaq Rules 5250(c)(1) and 5620(a) due to unfiled 10-K for 2022 and Q1-Q3 2023 10-Qs.
Trading suspended effective Feb. 29, 2024; Company will not appeal the Panel's decision.
Shares expected to be quoted on OTC market under ticker MDRX while working to regain compliance and relist.
Delisting triggers a 'make-whole fundamental change' under the indenture for Veradigm's outstanding convertible notes.
Company cites ongoing Audit Committee investigation and leadership changes as contributing factors to filing delays.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Veradigm Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1), 5620(a)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: late filing
Rules: 5250(c)(1), 5620(a)

Exact text from the filing

February 27, 2024, Veradigm Inc., a Delaware corporation (the “Company”), received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the common stock of the Company from Nasdaq (the “Decision”). The Decision indicates that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) and Nasdaq Listing Rule 5620(a). The Decision indicates that trading in the Company’s common stock will be suspended effective February 29, 2024. The Decision also indicates that the Company may, within 15 calendar days from

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-24-049131

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.